Prechter Fund Research Impact Report 2016
It is the Prechter Fund’s vision to personalize treatment of bipolar disorder and prevent recurrences to enable those with bipolar disorder to lead healthy and productive lives.
The study of bipolar disorder is the study of humanity; the throes of mania deliver an intense — almost unimaginable — euphoria, while the depths of depression draw people into a despair that has been compared to Dante's inferno. The distance between these states defines infinity; when depression sets in, happiness seems light years away and in the manic state one conquers the universe with little to no reserve. The passage of time is affected in inexplicable ways, dragging on in depression and flashing by in mania.
One cannot know bipolar disorder without knowing uncertainty. And knowing bipolar disorder drives many questions, but there is one fundamental question: how can this happen? And, the "How?" is naturally followed by "What can we do?" This year's impact report focuses on what we are doing to develop solutions for individuals with bipolar disorder. The underlying distinct biological mechanisms are the focus of our cellular and genetic research. We use technology to establish patterns of personal behavior and focus on identification of predictive features of disease to be able to anticipate mood episodes and subsequently intervene earlier.
The strengths and passions of our research team are vast, matched only by the dedication of our Prechter Longitudinal Study of Bipolar Disorder research participants, and the generous support of our donors.
Thank you for your support.
Melvin G. McInnis, M.D., FRCPsych
Principal Investigator, Heinz C. Prechter Bipolar Research Fund
Thomas B. and Nancy Upjohn Woodworth Professor of Bipolar Disorder and Depression
For questions, please contact Kat at email@example.com.
We would like to take this opportunity to recognize and extend our gratitude to those individuals and organizations who have supported bipolar disorder research at the University of Michigan. We thank them for their generosity and the difference they are making in bipolar research and treatment.